Combination effect of gallic acid and cisplatin on ros and GSH production of cervical cancer cells, hela

Cervical cancer is one of the leading causes of death among women worldwide. Unfortunately, most of the available cancer treatments reported to cause side effects. Therefore, patients turn to alternative treatments by utilizing natural products. Gallic acid (3,4,5‑trihydroxy benzoic acid; GA), a...

Full description

Saved in:
Bibliographic Details
Main Author: Nazri, Batrisyia Mohd
Format: Thesis
Language:en
Published: 2023
Subjects:
Online Access:http://eprints.usm.my/60246/1/Batrisyia-E.pdf
http://eprints.usm.my/60246/
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1834507305059614720
author Nazri, Batrisyia Mohd
author_facet Nazri, Batrisyia Mohd
author_sort Nazri, Batrisyia Mohd
building Hamzah Sendut Library
collection Institutional Repository
content_provider Universiti Sains Malaysia
content_source USM Institutional Repository
continent Asia
country Malaysia
description Cervical cancer is one of the leading causes of death among women worldwide. Unfortunately, most of the available cancer treatments reported to cause side effects. Therefore, patients turn to alternative treatments by utilizing natural products. Gallic acid (3,4,5‑trihydroxy benzoic acid; GA), a plant‑derived natural phenolic compound, has been reported to prevent the development and progression of various types of cancers. Anticancer activities of GA were reported due to regulation of reactive oxygen species (ROS) and glutathione (GSH) at the cellular level. However, its mechanism of action is still unclear. Thus, this study aimed to evaluate the regulations of ROS and GSH on the combination of cisplatin and GA in HeLa cells at 24 and 48 hours treatment period at IC50 concentration. ROS levels, including H2O2 concentrations were measured in HeLa cells as these variations appear to influence cervical cancer's vulnerability to cisplatin treatment over both the 24-hour and 48-hour intervals. Moreover, GSH levels were measured in treated HeLa cells as it helps to provide information about the intricate balance between the body's attempts to counter oxidative stress and the response of cervical cancer cells to the damage caused by the treatment. The results revealed that the combination of cisplatin and GA led to distinct patterns of ROS production for both the 24-hour and 48-hour intervals. This highlights the substantial influence of ROS levels on the treatment efficacy. Additionally, H2O2 levels was elevated during the 48-hour period when cisplatin and GA were combined. This increase aligned with the initiation of apoptosis, highlighting the time-dependent nature of H2O2 levels production, as the combination treatment demonstrated increased concentration after 48 hours. Moreover, during the 48-hour treatment
format Thesis
id my.usm.eprints.60246
institution Universiti Sains Malaysia
language en
publishDate 2023
record_format eprints
spelling my.usm.eprints.60246 http://eprints.usm.my/60246/ Combination effect of gallic acid and cisplatin on ros and GSH production of cervical cancer cells, hela Nazri, Batrisyia Mohd R Medicine RC254-282 Neoplasms. Tumors. Oncology (including Cancer) Cervical cancer is one of the leading causes of death among women worldwide. Unfortunately, most of the available cancer treatments reported to cause side effects. Therefore, patients turn to alternative treatments by utilizing natural products. Gallic acid (3,4,5‑trihydroxy benzoic acid; GA), a plant‑derived natural phenolic compound, has been reported to prevent the development and progression of various types of cancers. Anticancer activities of GA were reported due to regulation of reactive oxygen species (ROS) and glutathione (GSH) at the cellular level. However, its mechanism of action is still unclear. Thus, this study aimed to evaluate the regulations of ROS and GSH on the combination of cisplatin and GA in HeLa cells at 24 and 48 hours treatment period at IC50 concentration. ROS levels, including H2O2 concentrations were measured in HeLa cells as these variations appear to influence cervical cancer's vulnerability to cisplatin treatment over both the 24-hour and 48-hour intervals. Moreover, GSH levels were measured in treated HeLa cells as it helps to provide information about the intricate balance between the body's attempts to counter oxidative stress and the response of cervical cancer cells to the damage caused by the treatment. The results revealed that the combination of cisplatin and GA led to distinct patterns of ROS production for both the 24-hour and 48-hour intervals. This highlights the substantial influence of ROS levels on the treatment efficacy. Additionally, H2O2 levels was elevated during the 48-hour period when cisplatin and GA were combined. This increase aligned with the initiation of apoptosis, highlighting the time-dependent nature of H2O2 levels production, as the combination treatment demonstrated increased concentration after 48 hours. Moreover, during the 48-hour treatment 2023-08 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/60246/1/Batrisyia-E.pdf Nazri, Batrisyia Mohd (2023) Combination effect of gallic acid and cisplatin on ros and GSH production of cervical cancer cells, hela. Masters thesis, Universiti Sains Malaysia.
spellingShingle R Medicine
RC254-282 Neoplasms. Tumors. Oncology (including Cancer)
Nazri, Batrisyia Mohd
Combination effect of gallic acid and cisplatin on ros and GSH production of cervical cancer cells, hela
title Combination effect of gallic acid and cisplatin on ros and GSH production of cervical cancer cells, hela
title_full Combination effect of gallic acid and cisplatin on ros and GSH production of cervical cancer cells, hela
title_fullStr Combination effect of gallic acid and cisplatin on ros and GSH production of cervical cancer cells, hela
title_full_unstemmed Combination effect of gallic acid and cisplatin on ros and GSH production of cervical cancer cells, hela
title_short Combination effect of gallic acid and cisplatin on ros and GSH production of cervical cancer cells, hela
title_sort combination effect of gallic acid and cisplatin on ros and gsh production of cervical cancer cells, hela
topic R Medicine
RC254-282 Neoplasms. Tumors. Oncology (including Cancer)
url http://eprints.usm.my/60246/1/Batrisyia-E.pdf
http://eprints.usm.my/60246/
url_provider http://eprints.usm.my/